What is Acceletronics?
Founded in 1981, Acceletronics operates as a premier independent provider specializing in the maintenance, refurbishment, and installation of critical radiotherapy equipment, including linear accelerators and CT simulators. As the exclusive North American distributor for the TheraView portal imaging system, the company serves as a vital link in the healthcare supply chain. Its commitment to quality is evidenced by its status as the only independent linear accelerator service provider registered to ISO 9001:2008 standards, ensuring that medical facilities maintain high-performance diagnostic and treatment environments.
The company occupies a unique niche, bridging the gap between original equipment manufacturers and clinical providers. By offering cost-effective, high-quality refurbishment services, Acceletronics enables healthcare institutions to extend the lifecycle of their medical imaging assets while maintaining rigorous safety and precision standards required for modern oncology treatments.
How much funding has Acceletronics raised?
Acceletronics has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Acceletronics
PPP
Public-Private Partnership
What's next for Acceletronics?
With the successful acquisition of this strategic investment, Acceletronics is poised to accelerate its growth trajectory by scaling its service infrastructure and deepening its distribution reach. The company is expected to focus on integrating advanced diagnostic technologies and expanding its technical workforce to meet the rising demand for reliable, independent radiotherapy support. As the healthcare industry continues to prioritize the optimization of existing medical assets, Acceletronics is strategically aligned to capture further market share, potentially exploring new geographic territories or enhancing its proprietary service offerings to maintain its leadership in the radiotherapy equipment sector.
See full Acceletronics company page
